Spire Wealth Management Beam Therapeutics Inc. Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
SELL
$23.01 - $32.46 $11,620 - $16,392
-505 Reduced 69.18%
225 $5,000
Q2 2023

Aug 09, 2023
SELL
$29.32 - $35.99 $13,194 - $16,195
-450 Reduced 38.14%
730 $23,000
Q1 2023

May 09, 2023
SELL
$30.15 - $48.79 $129,192 - $209,065
-4,285 Reduced 78.41%
1,180 $36,000
Q4 2022

Feb 03, 2023
BUY
$36.73 - $51.6 $200,729 - $281,994
5,465 New
5,465 $214,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email